Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review
SUMMARY Severe hypertriglyceridemia accounts for up to 7% of all cases of acute pancreatitis. Heparin and insulin activate lipoprotein lipase (LPL), thereby reducing plasma triglyceride levels. However, the safety and efficacy of heparin and insulin in the treatment of hypertriglyceridemia-associate...
Main Authors: | Mohammad Shafi Kuchay, Khalid J. Farooqui, Tarannum Bano, Manoj Khandelwal, Harmandeep Gill, Ambrish Mithal |
---|---|
Format: | Article |
Language: | English |
Published: |
Brazilian Society of Endocrinology and Metabolism
2017-02-01
|
Series: | Archives of Endocrinology and Metabolism |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000200198&lng=en&tlng=en |
Similar Items
-
PRIMARY HYPERTRIGLYCERIDEMIA AND INSULIN THERAPY
by: Davis, T, et al.
Published: (1981) -
Hypertriglyceridemia-induced acute pancreatitis – Course, outcome, and comparison with non-hypertriglyceridemia associated pancreatitis
by: Syed Shafiq, et al.
Published: (2022-01-01) -
Hypertriglyceridemia–induced acute pancreatitis: A systematic review of the literature
by: Ionut Negoi, et al.
Published: (2017-01-01) -
TREATMENT OF TYPE-4 HYPERTRIGLYCERIDEMIA WITH INSULIN
by: Turner, R, et al.
Published: (1977) -
Hypertriglyceridemia induced recurrent pancreatitis case
by: Seda Karaaslan, et al.
Published: (2021-03-01)